Understanding the FDA ANDA Process: How Generic Drugs Get Approved
Learn how the FDA's Abbreviated New Drug Application (ANDA) process works to bring affordable generic drugs to market by proving therapeutic equivalence.
Read morePopular post
Tag: generic drugs
Patient Compliance Advantages with Generic Combination Products
Generic combination products simplify treatment by merging drugs and devices into one unit, cutting costs and improving adherence. Learn how they work, why they're more effective than multiple pills, and what to watch for when switching generics.
Read more
Generic Drug Concerns: Myths vs. Reality for Safety and Efficacy
Generic drugs save billions and are just as safe and effective as brand-name versions for most people. Learn the truth behind the myths - and when you should be cautious.
Read more
Economic Impact of Patent Expiration: How Drug Prices Drop After Patents Expire
When pharmaceutical patents expire, drug prices often drop by 80% or more as generics enter the market. This economic shift saves patients and insurers billions-but patent thickets and rebates can delay those savings for years.
Read more
How Bioequivalence Studies Are Conducted: Step-by-Step Process
Bioequivalence studies prove generic drugs work the same as brand-name versions by measuring how quickly and how much of the drug enters the bloodstream. This step-by-step process ensures safety, effectiveness, and cost savings across global healthcare systems.
Read more
How to Compare New Prescription Labels with Your Old Medication for Safety
Learn how to safely compare your new prescription label with your old one to avoid dangerous medication errors. Check the active ingredient, dosage, manufacturer, and pill appearance every time you refill.
Read more
Paragraph IV Certifications: How Generic Drug Makers Challenge Patents Before Launch
Paragraph IV certifications let generic drug makers challenge brand-name patents before launch, speeding up access to cheaper medicines. This legal tool under the Hatch-Waxman Act has saved U.S. consumers over $2 trillion since 1984.
Read more